Created at 12:58 p.m. Mar, 05, 2026
Author:
talma11
Rationale for change
Can you please add the dermatographix visual for the various biologics?
Current
Suggested
Dermatographix
Dermatographix
Dermatographix
Dermatographix
Text
Biologic treatments for psoriasis include:
TNF-α inhibitors: infliximab, etanercept, certolizumab, and adalimumab
IL-12/-23 inhibitor: {{c1::ustekinumab}}
IL-23 inhibitors: {{c3::guselkumab}}, {{c3::tildrakizumab}}, {{c3::risankizumab}}
IL-17 inhibitors: {{c2::secukinumab}}, {{c2::brodalumab}}, {{c2::ixekizumab}}, {{c2::bimekizumab}}
Extra
Guselkumab (Tremfya), tildrakizumab (Ilumya), risankizumab (Skyrizi)
Infliximab (Remicade), etanercept (Enbrel), certolizumab (Cimzia), adalimumab (Humira)
Ustekinumab (Stelara)
Guselkumab (Tremfya), tildrakizumab (Ilumya), risankizumab (Skyrizi)
Secukinumab (Cosentyx), brodalumab (Siliq), ixekizumab (Taltz), bimekizumab (Bimzelx)
Personal Notes
Empty field
Missed Questions
Empty field
DermPath
Empty field
Dermoscopy
Empty field
VisualDx
Empty field
DermNet
Empty field
Full Spectrum of Dermatology
Empty field
Dermnemonics
Empty field
Textbook
Empty field
Additional Resources
Empty field
One by one
Empty field